GenScript Biotech Corp 13D and 13G filings for Legend Biotech Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 8:34 pm Unchanged | 2023-12-31 | 13G | Legend Biotech Corporation LEGN | GenScript Biotech Corp | 174,497,556 47.990% | 0 (Unchanged) | Filing |
| 2023-02-14 4:02 pm Unchanged | 2022-12-31 | 13G | Legend Biotech Corporation LEGN | GenScript Biotech Corp | 174,497,556 52.120% | 0 (Unchanged) | Filing |
| 2022-03-11 5:02 pm Purchase | 2021-12-31 | 13G | Legend Biotech Corporation LEGN | GenScript Biotech Corp | 174,497,556 57.100% | 4,500,000 (+2.65%) | Filing |
| 2021-02-16 07:27 am Purchase | 2020-12-31 | 13G | Legend Biotech Corporation LEGN | GenScript Biotech Corp | 169,997,556 64.300% | 169,997,556 (New Position) | Filing |